injection site itching tirzepatide rash and skin & The Relationship Between Obesity & Issues Tirzepatide at Allergic Reaction Rash to Terzepatide – Injection Site Reaction Tirzepatide: Causes,

Both are studied for lipolytic activity, but AOD-9604 has additional published data on cartilage and bone research applications

W.et al (2012)

Cabaletta Bio Founded: 2017 Technology / disease area: Autologous CD19 CAR T in autoimmune diseases Lead candidate: rese-cel (formerly CABA-201) Philadelphia-based biotech company Cabaletta Bio is developing autologous CD19-directed CAR T therapies for autoimmune diseases, using an immune reset framing that borrows from oncology CAR T but targets chronic B-cell-driven pathology rather than malignant B cells

Both studies (Study 1 and 2) consisted of a 26-week Main Phase and a 26-week Extension Phase